Nicholas T Terrigino (Nicolas T Terrigino)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Locally Advanced

Radical Prostatectomy

Magnetic Resonance

Top Venues

medRxiv : the preprint server for health sciences

The Journal of urology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Scott Wilkinson, Anson T Ku, Rosina T Lis, Isaiah M King, Daniel Low, Shana Y Trostel, John R Bright, Nicholas T Terrigino, Anna Baj, John M Fenimore, Chennan Li, BaoHan Vo, Caroline S Jansen, Huihui Ye, Nichelle C Whitlock, Stephanie A Harmon, Nicole V Carrabba, Rayann Atway, Ross Lake, Haydn T Kissick, Peter A Pinto, Peter C Black, Ismail Baris Turkbey, William L Dahut, Fatima Karzai, Adam G Sowalsky
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition. medRxiv : the preprint server for health sciences (2024)
Scott Wilkinson, Anson T Ku, Rosina T Lis, Isaiah M King, Daniel Low, Shana Y Trostel, John R Bright, Nicholas T Terrigino, Anna Baj, John M Fenimore, Chennan Li, BaoHan Vo, Caroline S Jansen, Huihui Ye, Nichelle C Whitlock, Stephanie A Harmon, Nicole V Carrabba, Rayann Atway, Ross Lake, Haydn T Kissick, Peter A Pinto, Peter C Black, Ismail Baris Turkbey, William L Dahut, Fatima Karzai, Adam G Sowalsky
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition. medRxiv : the preprint server for health sciences (2024)
Scott Wilkinson, Anson T Ku, Rosina T Lis, Isaiah M King, Daniel Low, Shana Y Trostel, John R Bright, Nicholas T Terrigino, Anna Baj, John M Fenimore, Chennan Li, BaoHan Vo, Caroline S Jansen, Huihui Ye, Nichelle C Whitlock, Stephanie A Harmon, Nicole V Carrabba, Rayann Atway, Ross Lake, Haydn T Kissick, Peter A Pinto, Peter C Black, Ismail Baris Turkbey, William L Dahut, Fatima Karzai, Adam G Sowalsky
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition. medRxiv : the preprint server for health sciences (2024)
John R Bright, Rosina T Lis, Anson T Ku, Nicholas T Terrigino, Nichelle C Whitlock, Shana Y Trostel, Nicole V Carrabba, Stephanie A Harmon, Ismail Baris Turkbey, Scott Wilkinson, Adam G Sowalsky
Prostate-Specific Membrane Antigen Is a Biomarker for Residual Disease following Neoadjuvant Intense Androgen Deprivation Therapy in Prostate Cancer. The Journal of urology 208 (1) (2022)
Nichelle C Whitlock, Shana Y Trostel, Scott Wilkinson, Nicholas T Terrigino, S Thomas Hennigan, Ross Lake, Nicole V Carrabba, Rayann Atway, Elizabeth D Walton, Berkley E Gryder, Brian J Capaldo, Huihui Ye, Adam G Sowalsky
MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity. Oncogene 39 (34) (2020)
Fatima Karzai, Stephanie M Walker, Scott Wilkinson, Ravi A Madan, Joanna H Shih, Maria J Merino, Stephanie A Harmon, David J VanderWeele, Lisa M Cordes, Nicole V Carrabba, John R Bright, Nicholas T Terrigino, Guinevere Chun, Marijo Bilusic, Anna Couvillon, Amy Hankin, Monique N Williams, Rosina T Lis, Huihui Ye, Peter L Choyke, James L Gulley, Adam G Sowalsky, Baris Turkbey, Peter A Pinto, William L Dahut
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic Response. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)